Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1984 1
1985 1
1986 2
1988 1
1990 1
1991 2
1992 2
1993 2
1994 2
1995 4
1996 4
1997 1
1998 1
2000 1
2001 1
2002 2
2003 2
2004 2
2005 1
2006 3
2007 3
2008 3
2010 1
2011 3
2012 5
2013 1
2014 2
2015 3
2016 6
2017 5
2018 7
2019 6
2020 3
2021 6
2022 5
2023 8
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

97 results

Results by year

Filters applied: . Clear all
Page 1
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
Perkovic V, Jardine MJ, Neal B, Bompoint S, Heerspink HJL, Charytan DM, Edwards R, Agarwal R, Bakris G, Bull S, Cannon CP, Capuano G, Chu PL, de Zeeuw D, Greene T, Levin A, Pollock C, Wheeler DC, Yavin Y, Zhang H, Zinman B, Meininger G, Brenner BM, Mahaffey KW; CREDENCE Trial Investigators. Perkovic V, et al. N Engl J Med. 2019 Jun 13;380(24):2295-2306. doi: 10.1056/NEJMoa1811744. Epub 2019 Apr 14. N Engl J Med. 2019. PMID: 30990260 Free article. Clinical Trial.
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators. Salloway S, et al. N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839. N Engl J Med. 2014. PMID: 24450891 Free PMC article. Clinical Trial.
Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease.
Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Perrone RD, Koch G, Ouyang J, McQuade RD, Blais JD, Czerwiec FS, Sergeyeva O; REPRISE Trial Investigators. Torres VE, et al. N Engl J Med. 2017 Nov 16;377(20):1930-1942. doi: 10.1056/NEJMoa1710030. Epub 2017 Nov 4. N Engl J Med. 2017. PMID: 29105594 Free article. Clinical Trial.
Roadmap on thermoelectricity.
Artini C, Pennelli G, Graziosi P, Li Z, Neophytou N, Melis C, Colombo L, Isotta E, Lohani K, Scardi P, Castellero A, Baricco M, Palumbo M, Casassa S, Maschio L, Pani M, Latronico G, Mele P, Di Benedetto F, Contento G, De Riccardis MF, Fucci R, Palazzo B, Rizzo A, Demontis V, Prete D, Isram M, Rossella F, Ferrario A, Miozzo A, Boldrini S, Dimaggio E, Franzini M, Galliano S, Barolo C, Mardi S, Reale A, Lorenzi B, Narducci D, Trifiletti V, Milita S, Bellucci A, Trucchi DM. Artini C, et al. Among authors: mele p. Nanotechnology. 2023 May 9;34(29). doi: 10.1088/1361-6528/acca88. Nanotechnology. 2023. PMID: 37019100 Free article. Review.
Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease: Results From the CREDENCE Trial and Meta-Analysis.
Zhou Z, Jardine MJ, Li Q, Neuen BL, Cannon CP, de Zeeuw D, Edwards R, Levin A, Mahaffey KW, Perkovic V, Neal B, Lindley RI; CREDENCE Trial Investigators*. Zhou Z, et al. Stroke. 2021 May;52(5):1545-1556. doi: 10.1161/STROKEAHA.120.031623. Epub 2021 Apr 20. Stroke. 2021. PMID: 33874750 Free PMC article. Clinical Trial.
Pre- and postsynaptic N-methyl-D-aspartate receptors are required for sequential printing of fear memory engrams.
Bertocchi I, Rocha-Almeida F, Romero-Barragán MT, Cambiaghi M, Carretero-Guillén A, Botta P, Dogbevia GK, Treviño M, Mele P, Oberto A, Larkum ME, Gruart A, Sprengel R, Delgado-García JM, Hasan MT. Bertocchi I, et al. Among authors: mele p. iScience. 2023 Sep 25;26(11):108050. doi: 10.1016/j.isci.2023.108050. eCollection 2023 Nov 17. iScience. 2023. PMID: 37876798 Free PMC article.
Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial.
Yi TW, Smyth B, Di Tanna GL, Arnott C, Cardoza K, Kang A, Pollock C, Agarwal R, Bakris G, Charytan DM, de Zeeuw D, Heerspink HJL, Neal B, Wheeler DC, Cannon CP, Zhang H, Zinman B, Perkovic V, Levin A, Mahaffey KW, Jardine M; CREDENCE Trial Investigators. Yi TW, et al. Am J Kidney Dis. 2023 Jul;82(1):84-96.e1. doi: 10.1053/j.ajkd.2022.12.015. Epub 2023 Mar 7. Am J Kidney Dis. 2023. PMID: 36889425 Clinical Trial.
97 results